Pages that link to "Q34503413"
Jump to navigation
Jump to search
The following pages link to Myocardial gene therapy (Q34503413):
Displaying 50 items.
- The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo (Q24309200) (← links)
- Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors (Q24320033) (← links)
- Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization (Q24646424) (← links)
- Model‐specific selection of molecular targets for heart failure gene therapy (Q26823061) (← links)
- Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 (Q28187887) (← links)
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration (Q28207902) (← links)
- Growth factor activation in myocardial vascularization: therapeutic implications (Q28611472) (← links)
- Molecular regulation of vessel maturation (Q29614540) (← links)
- Angiogenesis in health and disease (Q29614541) (← links)
- A visible, targeted high-efficiency gene delivery and transfection strategy (Q30475161) (← links)
- Angiogenic therapy for coronary artery and peripheral arterial disease (Q30783593) (← links)
- Dose-dependent neovascularization-promoting effect of adenovirus vector CI-1023 in a rat hindlimb ischaemic model (Q31114069) (← links)
- New prospects in myocardial surgical revascularization (Q33230099) (← links)
- Alcohol-induced hypertension: Mechanism and prevention (Q33686885) (← links)
- Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation (Q34004811) (← links)
- Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). (Q34032032) (← links)
- Bioreducible polymers for therapeutic gene delivery (Q34079568) (← links)
- Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium (Q34134323) (← links)
- Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. (Q34136366) (← links)
- Gene transfer into genomes of human cells by the sleeping beauty transposon system. (Q34211504) (← links)
- Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease (Q34324856) (← links)
- Cardiac Gene Therapy (Q34409721) (← links)
- Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation (Q34431265) (← links)
- Molecular imaging of RNA interference therapy targeting PHD2 for treatment of myocardial ischemia (Q34601238) (← links)
- In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits (Q34717828) (← links)
- Heart failure in 10 years time: focus on pharmacological treatment. (Q34817094) (← links)
- Angiogenesis in ischemic and neoplastic disorders (Q34931041) (← links)
- Angiogenic functions of voltage-gated Na+ Channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling (Q34947687) (← links)
- Novel gene therapy approach for nasopharyngeal carcinoma (Q35008899) (← links)
- Targeting calcium cycling proteins in heart failure through gene transfer (Q35037546) (← links)
- Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. (Q35050037) (← links)
- Defining the success of cardiac gene therapy: how can nuclear imaging contribute? (Q35050717) (← links)
- Outcomes of middle cardiac vein arterialization via internal mammary/thoracic artery anastomosis. (Q35053796) (← links)
- Emerging therapeutic targets in chronic heart failure: part II. (Q35056026) (← links)
- Targeting signaling pathways in heart failure by gene transfer (Q35095401) (← links)
- Progress and problems with the use of viral vectors for gene therapy (Q35120176) (← links)
- Reprogramming cells for transplantation. (Q35184059) (← links)
- Polymeric growth factor delivery strategies for tissue engineering (Q35208978) (← links)
- Transplantation of endothelial progenitor cells for therapeutic neovascularization. (Q35218990) (← links)
- Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. (Q35397286) (← links)
- Angiogenesis: a curse or cure? (Q35521647) (← links)
- Cell transplantation and genetic engineering: new approaches to cardiac pathology (Q35547250) (← links)
- Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis (Q35554334) (← links)
- Manipulating angiogenesis in medicine (Q35743851) (← links)
- Hypoxia induces angiogenic factors in brain microvascular endothelial cells (Q35754099) (← links)
- Stem cells and repair of the heart. (Q35832759) (← links)
- Therapeutic myocardial angiogenesis: past, present and future (Q35949643) (← links)
- Current clinical perspectives on myocardial angiogenesis. (Q35949692) (← links)
- Cardiovascular gene therapy: current status and therapeutic potential. (Q35995220) (← links)
- Noninvasive imaging of cardiac gene expression and its future implications for molecular therapy (Q36136721) (← links)